ObjectiveHealth Overview
- Year Founded
-
2018

- Status
-
Private
- Employees
-
115

- Latest Deal Type
-
Later Stage VC
- Investors
-
3
ObjectiveHealth General Information
Description
Developer of a clinical research platform intended to improve patient outcomes at the point of care. The company offers tools needed to integrate clinical trials into practice and utilizes proprietary technology, and processes to deliver significant advances in the conduct of research, enabling physicians and healthcare organizations to establish advanced infrastructure for research programs and to gain access to trials within their community.
Contact Information
Website
www.objective.healthCorporate Office
- 341 Cool Springs Boulevard
- Suite 450
- Franklin, TN 37067
- United States
Corporate Office
- 341 Cool Springs Boulevard
- Suite 450
- Franklin, TN 37067
- United States
ObjectiveHealth Timeline
ObjectiveHealth Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC | 26-Jan-2024 | Completed | Generating Revenue | |||
5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
4. Later Stage VC (Series C) | 21-Nov-2022 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 25-Mar-2021 | Completed | Generating Revenue | |||
2. Debt - PPP | 13-Apr-2020 | $498K | $6.62M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 09-Dec-2019 | $6.62M | $6.62M | Completed | Generating Revenue |
ObjectiveHealth Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B | ||||||||
Series A-3 | ||||||||
Series A-2 | 1,743,467 | $0.000010 | $0.03 | $0.42 | $0.42 | 1x | $0.42 | 5.61% |
Series A-1 | 4,539,171 | $0.000010 | $0.06 | $0.93 | $0.93 | 1x | $0.93 | 14.61% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ObjectiveHealth Patents
ObjectiveHealth Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220383995-A1 | System and method for identifying candidates for clinical trials | Active | 28-May-2021 | ||
US-12211595-B2 | System and method for identifying candidates for clinical trials | Active | 28-May-2021 | ||
US-20250125022-A1 | System and method for identifying candidates for clinical trials | Pending | 28-May-2021 | G16H10/20 |
ObjectiveHealth Signals
ObjectiveHealth Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Vitruvian Partners | PE/Buyout | Minority | ||
BIP Ventures | Venture Capital | Minority | ||
NueCura Partners | Angel Group | Minority |
ObjectiveHealth FAQs
-
When was ObjectiveHealth founded?
ObjectiveHealth was founded in 2018.
-
Where is ObjectiveHealth headquartered?
ObjectiveHealth is headquartered in Franklin, TN.
-
What is the size of ObjectiveHealth?
ObjectiveHealth has 115 total employees.
-
What industry is ObjectiveHealth in?
ObjectiveHealth’s primary industry is Other Healthcare Technology Systems.
-
Is ObjectiveHealth a private or public company?
ObjectiveHealth is a Private company.
-
What is ObjectiveHealth’s current revenue?
The current revenue for ObjectiveHealth is
. -
How much funding has ObjectiveHealth raised over time?
ObjectiveHealth has raised $21.3M.
-
Who are ObjectiveHealth’s investors?
Vitruvian Partners, BIP Ventures, and NueCura Partners have invested in ObjectiveHealth.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »